Community-based clinical trial
From Wikipedia, the free encyclopedia
Community-based clinical trials are clinical trials conducted directly through doctors and clinics rather than academic research facilities. They are designed to be administered through primary care physicians, community health centers and local outpatient facilities. In 1986, the Community Consortium held the first such trials in the United States to determine the efficiacy of preventative treatments after the onset of Pneumocystis pneumonia.[1] The trials give patients access to new medications and keep doctors involved with new developments in research. However, critics state that drug company payments to doctors for patients enrolled in such studies present a conflict of interest and potential for abuse.[2][3] Community-based trials are becoming prevalent in human-testing stage pharmaceutical research.
[edit] References
- ^ University of Texas Medical Branch, AIDS Clinical Trials Unit, "History of CABs"
- ^ "Community-based trials under scrutiny" by Phyllis Maguire, July/August 1999 ACP-ASIM Observer
- ^ "The tribulations of community-based trials" by Ann Silversides , January 6, 2004 Canadian Medical Association Journal
[edit] See also
[edit] External links
- The Community Programs for Clinical Research on AIDS
- "Considerations for Community-Based Research With African American Women"
- "Scientific Justification for Community-Based Trials"
 |
This medical article is a stub. You can help Wikipedia by expanding it. |
